Suleiman Zakari A, Kolawole Israel K, Okeyemi Ajibade
Department of Anaesthesia, Faculty of Clinical Sciences, University of Ilorin, Ilorin 240001, Nigeria.
Department of Anaesthesia, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Ghana Med J. 2018 Sep;52(3):153-157. doi: 10.4314/gmj.v52i3.8.
The injection of mixture of plain bupivacaine and triamcinolone acetonide into the sacroiliac joint (SIJ) to relieve chronic low back pain is uncommon in the West African sub-region. The objective of this study was to demonstrate the efficacy or otherwise of fluoroscopic-guided SI joint injection in the management of chronic axial low back pain in Nigeria.
This was a prospective observational interventional study.
The study was carried out at a tertiary hospital in Nigeria.
Twenty-six patients with SI joint pain, based on IASP diagnostic criteria, who presented to our unit over 36 months from March 2012 to March 2015 and.
Fluoroscopic-guided injections of 5mls mixture of bupivacaine and triamcinolone acetonide into the sacro-iliac (SI) joints of 26 patients with SI joint pain out of 116 patients who were offered different interventions for chronic low back pain. The patients were followed up for year and pain intensity and functional status were assessed at 3-, 6- and 12 months post-intervention.
Pain relief and functional improvement were the main outcome measures.
The mean numeric rating score (NRS) and Oswestry Disability index (ODI) score in 14 (53.9%) patients at 12 months post-interventions were significantly lower compared with baseline values; 3.19 ± 1.10 vs 8.54 ±1.14 p=0.000 and 25.35 ± 5.40 vs 37.54 ±8.41, p=0.000 respectively.
Fluoroscopic-guided steroid injection into the SI joint resulted into reduction in pain intensity and improved physical function in the majority of patients with SI joint pain.
Not declared.
在西非次区域，向骶髂关节注射布比卡因和曲安奈德混合物以缓解慢性腰痛的情况并不常见。本研究的目的是证明在尼日利亚，荧光镜引导下的骶髂关节注射对慢性轴性腰痛的治疗效果。
这是一项前瞻性观察性干预研究。
该研究在尼日利亚的一家三级医院进行。
根据国际疼痛研究协会（IASP）诊断标准，2012年3月至2015年3月的36个月期间，有26名骶髂关节疼痛患者到我们科室就诊。
在116名因慢性腰痛接受不同干预措施的患者中，对26名骶髂关节疼痛患者进行荧光镜引导下向骶髂关节注射5毫升布比卡因和曲安奈德的混合物。对患者进行了为期一年的随访，并在干预后3个月、6个月和12个月评估疼痛强度和功能状态。
疼痛缓解和功能改善是主要观察指标。
干预后12个月，14名（53.9%）患者的平均数字评分量表（NRS）和奥斯维斯特残疾指数（ODI）评分与基线值相比显著降低；分别为3.19±1.10 vs 8.54±1.14，p = 0.000和25.35±5.40 vs 37.54±8.41，p = 0.000。
荧光镜引导下向骶髂关节注射类固醇可使大多数骶髂关节疼痛患者的疼痛强度降低，身体功能改善。
未声明。
